Clinical Trial Update: Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102) [Phase 4]

View source ↗

Summary

The ACCEPT-study (BY9010/CA-102), a Phase 4 trial evaluating Alvesco (ciclesonide) for asthma care in adults in primary care, has completed and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Alvesco (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2010-03-26